Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
NIH nixes financing for Pluri's radiation exposure cell therapy
The government terminated the contract in a move that Pluri said “may reflect broader federal budgetary and administrative adjustments” at the NIH.
Nick Paul Taylor
Apr 18, 2025 9:10am
Adaptimmune questions own longevity, axes preclinical funding
Mar 20, 2025 2:04pm
BioNTech passes on Autolus' CAR-T amid pipeline prioritization
Mar 20, 2025 9:11am
Cell therapy biotech axes cancer trial, turns to autoimmune
Mar 19, 2025 5:35pm
UK cell programming biotech lays off 25% of staff
Mar 19, 2025 3:05pm
Orca prepares to make market plunge after phase 3 win
Mar 17, 2025 7:00am